Yuqing Chen Selected Research

myristoyl-CM4

1/2019	Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis and/or apoptosis pathway.
1/2018	N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuqing Chen Research Topics

Disease

40	Neoplasms (Cancer) 01/2022 - 05/2011
13	Hypertension (High Blood Pressure) 01/2022 - 05/2007
12	Inflammation (Inflammations) 10/2021 - 10/2014
11	Infections 01/2022 - 05/2011
11	Lung Neoplasms (Lung Cancer) 10/2020 - 11/2002
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 08/2003
8	Fibrosis (Cirrhosis) 01/2022 - 01/2013
7	Proteinuria 07/2022 - 01/2009
7	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2015
6	Chronic Renal Insufficiency 07/2022 - 01/2010
6	Adenocarcinoma of Lung 01/2021 - 05/2011
6	IGA Glomerulonephritis (IGA Nephropathy) 07/2017 - 01/2009
5	Chronic Kidney Failure (Chronic Renal Failure) 06/2022 - 03/2008
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2013
5	Pneumonia (Pneumonitis) 12/2021 - 10/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2018
4	Body Weight (Weight, Body) 07/2021 - 01/2018
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2011
4	Osteoporosis 01/2021 - 03/2008
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021 - 01/2018
4	Leukemia 05/2020 - 04/2013
3	Anemia 06/2022 - 01/2018
3	Respiratory Insufficiency (Respiratory Failure) 05/2022 - 02/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2013
3	Multiple Myeloma 10/2021 - 05/2014
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 01/2018
3	Lung Injury 10/2020 - 01/2019
3	Virus Diseases (Viral Diseases) 02/2020 - 03/2018
3	Necrosis 01/2019 - 01/2013
3	Osteoarthritis 01/2019 - 03/2013
3	Asthma (Bronchial Asthma) 01/2019 - 10/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 05/2016
3	Osteogenesis Imperfecta (Lobstein Disease) 06/2017 - 01/2014
3	Acute Lung Injury 06/2015 - 08/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2022 - 05/2016
2	Heart Failure 01/2022 - 06/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2022
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2015
2	Disease Progression 01/2022 - 10/2019
2	Obesity 10/2021 - 06/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021 - 06/2019
2	Insulin Resistance 01/2021 - 01/2012
2	Influenza in Birds (Avian Flu) 02/2020 - 09/2018
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
5	LigandsIBA 05/2021 - 01/2013
5	AntigensIBA 10/2020 - 01/2013
5	UromodulinIBA 01/2020 - 01/2013
4	Peptides (Polypeptides)IBA 10/2020 - 03/2008
4	Messenger RNA (mRNA)IBA 02/2018 - 03/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2010
4	CatecholaminesIBA 01/2012 - 10/2008
4	Chromogranin AIBA 11/2010 - 03/2008
3	CytokinesIBA 01/2022 - 01/2018
3	InflammasomesIBA 01/2022 - 11/2018
3	Lipoproteins (Lipoprotein)IBA 10/2021 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 11/2018
3	Bortezomib (Velcade)FDA Link 10/2021 - 01/2019
3	Particulate MatterIBA 07/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
3	Adenosine Monophosphate (AMP)IBA 12/2020 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 09/2020 - 05/2011
3	OzoneIBA 07/2019 - 10/2014
3	Decitabine FDA Link 01/2019 - 02/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2009
2	GlucocorticoidsIBA 07/2022 - 10/2014
2	CalciumIBA 07/2022 - 05/2011
2	Epoetin Alfa (Epogen)FDA Link 06/2022 - 03/2022
2	Darbepoetin alfa (Aranesp)FDA Link 06/2022 - 03/2022
2	Erythropoietin FDA Link 06/2022 - 03/2022
2	Hemoglobins (Hemoglobin)IBA 03/2022 - 01/2022
2	squamous cell carcinoma-related antigenIBA 01/2022 - 10/2020
2	Piwi-Interacting RNAIBA 01/2022 - 01/2021
2	Collagen Type I (Type I Collagen)IBA 07/2021 - 01/2016
2	Indicators and Reagents (Reagents)IBA 02/2021 - 10/2020
2	CholesterolIBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2019
2	Angiogenesis InhibitorsIBA 01/2021 - 08/2012
2	AlbuminsIBA 01/2021 - 05/2007
2	Cytochromes c (Cytochrome c)IBA 12/2020 - 01/2018
2	VaccinesIBA 10/2020 - 02/2014
2	EpitopesIBA 10/2020 - 02/2020
2	Antimicrobial PeptidesIBA 09/2020 - 01/2018
2	AntibodiesIBA 02/2020 - 09/2018
2	UbiquitinIBA 01/2020 - 04/2013
2	Hormones (Hormone)IBA 01/2020 - 11/2014

Therapy/Procedure

19	Therapeutics 05/2022 - 01/2009
6	Renal Dialysis (Hemodialysis) 06/2022 - 10/2019
6	Drug Therapy (Chemotherapy) 01/2022 - 08/2003
3	Immunotherapy 01/2021 - 12/2013
2	Artificial Respiration (Mechanical Ventilation) 02/2021 - 06/2015
2	Lasers (Laser) 09/2020 - 01/2018